Read the latest interims.......just make sure that you are sitting down.

Very interesting news out today from one of those PUSHING this one in the past.

They've got rid of stock before the results..........

Growth Company Investor

SovGEM - BUY
Companies: SOV
24/04/2007

Profiled by Growth Company Investor at 14.25p, SovGEM has appreciated in share price terms yet remains substantially undervalued given its net asset value (NAV) growth record under loquacious chief executive Hugh de Lusignan.

The emerging market finance house invests in early-stage businesses, mainly in China or PRC-related markets, and issued strong finals for the year to December. The highlight was 51.6% NAV growth to 27.9p, substantially north of the current share price, which looks illogically discounted.

Profits increased from 270,000 to 1m, driven by an increase in realised gains on investment disposals from 450,000 to 1.59m. Realised gains reflected a number of transactions, among them the timely sale of the entire stake in fertilizer maker and first investee Bodisen Biotech, part disposal of its stake in AIM-star Renesola, and the sale of part of its holding in Harbin Electric, a Chinese linear motor maker now quoted on NASDAQ. Encouragingly, the numbers also revealed unrealised gains of 1.59m within the portfolio, up from 1.05m in 2005.

SovGEMs investment focus remains on profitable, early-stage listed or pre-IPO companies that are usually Chinese domestic demand-led, with the investment timing typically tied to a fundraising event, an IPO or graduation to a more senior market.

During 2006, the number of investments burgeoned from four to 15, while three new investments have been added since year-end, and two follow-on investments have been completed. NAV growth continues apace, with directors best estimate of today's NAV akin to 30.67p, representing 143% NAV growth since the group's flotation.

The share price discount to assets might reflect investor concerns about the risks of investing in China as well as early stage businesses generally. However, given managements track record of NAV accretion and de Lusignans palpable enthusiasm for an array of investments within the portfolio, we expect that discount to narrow with news flow.

James Crux
Market cap: 5.24m
PE Forecast: n/a
Share price: 23p .............................. ENDS

But they didnt show up on the last RNS from sola on fund participation.............

ReneSola Ltd ("ReneSola" or the "Company")

Significant Shareholdings in the Company

The Company has undertaken a review of its share register and discloses below
the Company's Significant Shareholders (being a shareholder of 3 per cent or
more of the Company's issued shares) as at 9 February 2007.

The information contained below was obtained from the Company's registrar.

Shareholder Number of Shares Percentage
Interest

Li Xian Shou* 39,534,019 39.5

Wu Yun Cai** 20,366,010 20.4

Diverso Management Limited 6,604,164 6.6

Morgan Stanley Investment Management 3,138,945 3.1

*Mr. Li Xian Shou's shareholding is held through Ruixin Holdings Ltd, a company
incorporated and registered in the BVI.

**Mr. Wu Yun Cai's shareholding is held through Yuncai Holdings Ltd, a company
incorporated and registered in the BVI.

Following this review the Company has become aware that the following parties
are no longer Significant Shareholders.

The Eureka (Euro) Fund Limited

Polar Capital Partners Limited

Improve Forever Investments Ltd

RAB Capital plc (including shares held by RAB Special Situations (Master) Fund
Ltd and RAB New Technologies (Master) Fund Ltd)

The Eureka Interactive Fund Limited

Enquiries:-

In China:

Charles Bai, CFO

ReneSola Ltd

Tel: +86 573 477 3061, +86 573 477 3058

Email: charles.bai@renesola.com

In the UK:

Charles Ryland/Suzanne Brocks/Catherine Breen

Buchanan Communications

Tel: +44 20 7466 5000

Tim Feather

Hanson Westhouse Limited

Tel: +44 113 246 2610

Email: tim.feather@hansonwesthouse.com

so SOLA's results are out, but as i have trouble reading and understanding the Sunday Sport, don't expect me to analyise them ..... howvere, i do note that the result would seem no better than forecast back in February, so my guess there will be a lot of disappointed punters, especially on the back of the convertoible bond issue which was NOT (I think) forecast in February

Me too Cynic, although I note on top of the Convertible Loan issue they are looking for addional funding via a bank loan........hmm. We'll soon find out what the experts think when the market opens.

pth

Also not encouraged by the "Funding" statement - clearly discussions not finalised and funding of capacity expansion/associated working capital looks like a big issue.

but the market seems to like the figures, at least for the moment .... sp currently +35

but look at the volume

Everyone's jumping for joy on the board but I just don't see it personally...

Not much on the order book either, wonder if it will start to drift down?

I expect to see in close in the red.

snap .... but shall watch with interest rather than go short (i think!) ... chart below shows 25+dma converging at about 520 which will or at least should give quite solid support .... of course, if that is broken with any impetus, then a short may be the order of the day





red = 25 dma
green = 50 dma

This is being shorted, watch L2, everytime I put a sell order in at the Offer, I get gazumped! That's why it's ticking down.

PT .... are you trying to sell your holding or to go short?

Short using DMA

This is a BUY.

I don't think so hlyeo. The funding/expansion issue has not gone away.

Err, seem to have a few cash flow problems, burnt through the $120m and now off to the bank for another loan. Any slowdown in revenues due to manufacturing problems (expirenced already) or reduction in sales and they could be in trouble. But to be honest I don't really give a stuff either way.

Well after wading through all the puffery at the top of the accounts if one looks at the cash flow statement theres nothing there that as changed from quater three.

Cash outflow on working operations of just over 14 million. And a ever rising inventory.

Little wonder they need further banking arrangements on top of the bond issue.

Some across the road are not looking at the finer detail.

On 16 February 2007, the Company indicated that the consolidated profit before
and after tax for 2006 would be in the range of US$22-23 million. Reported
profit before tax is US$22.8 million. Total IPO costs were US$4.1 million, of
this amount US$0.4 million has been charged against profit for the year and
US$3.7 million against the share premium account.

Can anyone find any mention on margins which were dropping last quarter?.

How on earth this one as got away without it being called a profit warning is mind bogling.

No met up with any of the Brokers forecasts.

in that case, y is sp defying gravity?